Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis.

Sapol ThepwiwatjitSuranut CharoensriWichien SirithanapholAjanee MahakkanukrauhSiraphop SuwannarojChingching Foocharoen

Published in: Journal of scleroderma and related disorders (2022)

Around one-quarter of male systemic sclerosis patients had primary hypogonadism. Elderly onset of systemic sclerosis, hypertriglyceridemia, and late corticosteroid treatment were risk factors for developing primary hypogonadism.

Keyphrases

systemic sclerosis
interstitial lung disease
replacement therapy
end stage renal disease
chronic kidney disease
risk factors
patient reported outcomes